(Q43784547)

26 November 2017

title

Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive type 1 diabetic subjects (English)

1 reference

26 November 2017

1 reference

O Açbay

1

1 reference

26 November 2017

publication date

1 September 2001

1 reference

Journal of Endocrinological Investigation

26 November 2017

published in

1 reference

26 November 2017

volume

24

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

608-611

1 reference

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03343901

Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343901

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343901

Pathogenesis, prevention, and treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343901

Prevention of diabetic renal disease with special reference to microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343901

Angiotensin receptors and their antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343901

Angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343901

Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343901

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

21 January 2018

1 reference

12 December 2020

Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes

1 reference

12 December 2020

Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies

1 reference

12 December 2020

Effect of long-term losartan administration on renal haemodynamics and function in hypertensive patients

1 reference

12 December 2020

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

1 reference

12 December 2020

Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats

1 reference

12 December 2020

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

12 December 2020

Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension

1 reference

12 December 2020

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

1 reference

12 December 2020

Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03343901

1 reference

Dimensions Publication ID

26 November 2017

1018211004

0 references

1 reference